From: The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study
 | Actual scores Mean ± SD | Performance for healthy norms by age and gender | Equivalent functional age (years) | |
---|---|---|---|---|
Gait speed [26] (m/s) | Age 18–49 | Male: 1.12 ± 0.23 | Males: 1.46 ± 0.9 | Males: 80–89 |
Female: 1.09 ± 0.23 | Female: 1.42 ± 1.3 | Females: 80–89 | ||
Age ≥ 50 | Male: 1.09 ± 0.14 | Males: 1.36 ± 2.1 | Males: 80–89 | |
Female: 1.19 ± 0.15 | Female: 1.30 ± 2.1 | Females: 80–89 | ||
Age 18–49 | Male: 8.9 ± 1.6 | Males: 8.6 ± 1.2 | Males: 70–79 | |
Female: 9.5 ± 2.8 | Females: 8.6 ± 1.2 | Females: 70–79 | ||
Age ≥ 50 | Male: 10.7 ± 2.0 | Males: 8.0 ± 2 | Males: 80–89 | |
Female: 9.5 ± 1.1 | Females: 8.0 ± 2 | Females: 80–89 | ||
30-second chair stand [28] (#) | Age 18–49 | Male: 15 ± 5 | Males: N/A | Males: 65–69 |
Female: 13 ± 5 | Females: N/A | Females: 65–69 | ||
Age ≥ 50 | Male: 10 ± 4 | Males: 16 ± 4.3 | Males: 85–89 | |
Female: 12 ± 3 | Females: 15 ± 4.0 | Females: 75–79 | ||
Age 18–49 | Male: 585 ± 104 | Male: 638 ± 44 | Males: 60–69 | |
Female: 498 ± 118 | Female: 593 ± 57 | Female: 60–69 | ||
Age ≥ 50 | Male: 465 ± 73 | Male: 572 ± 92 | Males: 80–84 | |
Female: 499 ± 64 | Female: 538 ± 92 | Female: 70–74 |